Open AccessAllelic spectrum of formiminotransferase‐cyclodeaminase gene variants in individuals with formiminoglutamic aciduria
Author(s) -
Majumdar Ramanath,
Yori Andrew,
Rush Peggy W.,
Raymond Kimiyo,
Gavrilov Dimitar,
Tortorelli Silvia,
Matern Dietrich,
Rinaldo Piero,
Feldman Gerald L.,
Oglesbee Devin
Publication year - 2017
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.333
Subject(s) - frameshift mutation , genetics , biology , missense mutation , allele , gene , phenotype
Abstract Background Elevated plasma and urine formiminoglutamic acid ( FIGLU ) levels are commonly indicative of formiminoglutamic aciduria ( OMIM #229100), a poorly understood autosomal recessive disorder of histidine and folate metabolism, resulting from formiminotransferase‐cyclodeaminase ( FTCD ) deficiency, a bifunctional enzyme encoded by FTCD . Methods In order to further understanding about the molecular alterations that contribute to FIGLU ‐uria, we sequenced FTCD in 20 individuals with putative FTCD deficiency and varying laboratory findings, including increased FIGLU excretion. Results Individuals tested had biallelic loss‐of‐function variants in protein‐coding regions of FTCD . The FTCD allelic spectrum comprised of 12 distinct variants including 5 missense alterations that replace conserved amino acid residues (c.223A>C, c.266A>G, c.319T>C, c.430G>A, c.514G>T), an in‐frame deletion (c.1373_1375del TGG ), with the remaining alterations predicted to affect mRNA processing/stability. These included two frameshift variants (c.990dup, c.1366dup) and four nonsense variants (c.337C>T, c.451A>T, c.763C>T, c.1607T>A). Conclusion We observed additional FTCD alleles leading to urinary FIGLU elevations, and thus, providing molecular evidence of FTCD deficiency in cases identified by newborn screening or clinical biochemical genetic laboratory testing.